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Abstract 
Endothelial cell (EC) dysfunction (enhanced inflammation, proliferation and permeability) 
is the initial trigger for atherosclerosis. Atherosclerosis shows preferential development 
near branches and bends exposed to disturbed blood flow. By contrast, sites that are 
exposed to non-disturbed blood flow, are atheroprotected. Disturbed flow promotes 
atherosclerosis by promoting EC dysfunction. Blood flow controls EC function through 
transcriptional and post-transcriptional mechanisms that are incompletely understood. 
We identified the developmental transcription factors Twist1 and GATA4 as being 
enriched in EC at disturbed flow, atheroprone regions of the porcine aorta in a microarray 
study. Further work using the porcine and murine aortae demonstrated that Twist1 and 
GATA4 expression was enhanced at the atheroprone, disturbed flow sites in vivo. Using 
controlled in vitro flow systems, the expression of Twist1 and GATA4 was enhanced 
under disturbed compared to non-disturbed flow in cultured cells. Disturbed flow 
promoted Twist1 expression through a GATA4-mediated transcriptional mechanism as 
revealed by a series of in vivo and in vitro studies. GATA4-Twist1 signalling promoted EC 
proliferation, inflammation, permeability and EndoMT under disturbed flow, leading to 
atherosclerosis development, as shown in a combination of in vitro and in vivo studies 
using GATA4 and Twist1-specific siRNA and EC-specific GATA4 and Twist1 KO mice. 
We revealed that GATA4-Twist1-Snail signalling triggers EC dysfunction and 
atherosclerosis, this work could lead to the development of novel anti-atherosclerosis 
therapeutics. 
 
Introduction 
Atherosclerosis is a chronic, inflammatory disease of the vasculature that gives rise to 
heart attacks and stroke. Endothelial cells (EC) that line the vasculature play a central 
role in mediating vascular health, and EC dysfunction is the initial trigger for 
atherosclerosis. ECs are in direct contact with the flowing blood that exerts a mechanical 
drag known as shear stress. Despite the contribution of systemic risk factors (age, 
obesity, high cholesterol, age, smoking), atherosclerosis shows a non-random distribution 
in the vasculature. Atherosclerotic plaques show a preferential development at bends and 
branch points; these vascular sites are exposed to disturbed blood flow, which generates 
multidirectional, low wall shear stress. Whereas, sites that are exposed to non-disturbed 
flow, that exerts uniform, high shear stress are atheroprotected (Kwak et al., 2014, Suo 
et al., 2007, Dai et al., 2004, Passerini et al., 2004). Disturbed flow induces 
atherosclerosis development by promoting EC dysfunction (enhanced inflammation and 
proliferation) (Dai et al., 2004, Passerini et al., 2004, Schober et al., 2014, Guo et al., 
2007). As a result of enhanced proliferation, ECs lose contact with neighbouring cells and 
become more permeable to inflammatory cells and molecules (LDL), leading to 
atherosclerotic lesion formation (Cancel et al., 2011). Blood flow promotes EC 
dysfunction through modulating endothelial gene expression by molecular mechanisms 
that are not fully understood (Passerini et al., 2004, Cuhlman et al., 2011, Senbanerjee 
et al., 2003, Dunn et al., 2014, Ni et al., 2010). 
 
To further characterize the molecular mechanisms that control focal atherogenesis, we 
conducted a microarray study which revealed that the transcription factors Twist1 and 
GATA4 showed enhanced gene expression in EC at disturbed flow, atheroprone regions 
of the porcine aorta (Serbanovic-Canic et al., 2017). Both of these transcription factors 
control major developmental processes, Twist1 controls gastrulation during 
embryogenesis (Thisse et al., 1988), whereas GATA4 is a master regulator of cardiac 
development (Kuo et al., 1997). Although the role of Twist1 and GATA4 in embryonic 
development is well characterized, their potential function in ECs and vascular disease is 
entirely unknown. 
 
The role of GATA4 and Twist1 in embryonic development. 
GATA4 controls heart development. 
GATA4 is a zinc finger transcription factor that belongs to the GATA family, containing 
GATA1-GATA6 proteins. GATA proteins play non-redundant roles and display tissue-
specific expression; GATA1-3 are more closely related in sequence and are 
predominantly expressed in the hematopoietic system, whereas GATA4-6 are more 
closely related and are expressed in the cardiovascular system and the gonads (Zhou et 
al. 2012). The process of mammalian heart development begins with looping of the early 
heart tube (consisting of cardiomyocytes and endothelial cells), which then becomes 
divided into four chambers that are separated by endocardial cushion-mediated valve 
formation. This process is controlled by a tightly regulated cardiac transcriptional network. 
GATA4 is regarded as a master cardiac transcription factor as it acts upstream of the 
transcriptional network controlling heart development, including myocyte enhancer factor 
(Mef)2c, NK2 homeobox 5 (Nkx2.5), serum response factor (Srf) and Hand2 (Schlesinger 
et al. 2011; McFadden et al. 2000; E. M. Zeisberg et al.2007). Grepin et al. established 
the dominant role of GATA4 in cardiac development by revealing that GATA4 
overexpression in pluripotent P19 embryonic carcinoma cells committed the cells to 
undergo differentiation to the cardiac lineage and gave rise to beating cardiomyocytes 
(Grepin et al. 1995). Genetic inhibition of GATA4 restricted beating cardiomyocyte 
differentiation (Grepin et al. 1995), thus indicating that GATA4 expression is required to 
drive cardiomyocyte differentiation. Interestingly, when overexpressed in embryonic stem 
cells, GATA4 induces extraembryonic endoderm, not cardiomyocytes (Fujikura et al., 
2002). However, under defined culture conditions (serum-free media), GATA4 is able to 
efficiently promote cardiogenesis in embryonic stem cell derivatives (Turbendian et al., 
2013). Mice lacking GATA4 die before the onset of heart development due to defects in 
the extraembryonic endoderm (Kuo et al., 1997; Molkentin et al., 1997), while rescue 
experiments providing the null embryos with wild-type extraembryonic endoderm showed 
that GATA4 is required for cardiogenesis and proepicardium development (Watt et al., 
2004). 
 
Twist1 plays a major role in multiple stages of embryonic development. 
Twist1 is a transcription factor that belongs to the basic Helix-Loop-Helix (bHLH) family 
of transcriptional regulators. Twist1 was originally discovered in Drosophila, as one of the 
genes essential for mesoderm specification (Thisse et al, 1987). Drosophila embryos 
lacNLQJWKH7ZLVWJHQHGLHGGXULQJHPEU\RJHQHVLVZLWKD³WZLVWHG´DSSHDUDQFH7KLVVH
et al, 1987). In mouse, Twist1 plays a crucial role during multiple stages of embryonic 
development, from controlling mesodermal differentiation during gastrulation (around 
embryonic day (E) 6, up to controlling valve formation at E 16 (Reviewed in Qin et al. 
2012).  
 
Twist1 also acts as a master regulator of the osteoblast differentiation program by 
controlling the activity of downstream pathways that are central to osteoblast 
differentiation and development, including fibroblast growth factor (FGF) and bone 
morphogenic protein (BMP) signalling by controlling FGFR2, FGF8, FGF10, and BMP4 
transcription (Bialek et al. 2004; Connerney et al. 2008; Loebel et al. 2002; Rice et al. 
2010). 
 
GATA4 and Twist1 promote heart valve formation through endothelial-to 
mesenchymal transition. 
GATA4 and Twist1 exert overlapping functions during atrioventricular valve development 
by inducing endothelial-to-mesenchymal transition (EndoMT), which describes a process 
in which mature endothelial cells adopt a mesenchymal phenotype. Markwald et al 
discovered EndoMT as a critical process during heart valve development, where it was 
observed that cells of the endocardium acquire a more mesenchymal identity and 
participate to the formation of the mesenchymal heart cushion, the precursor of the 
cardiac valves (Markwald et al. 1975). Ultimately, EndoMT cells separate from the 
monolayer and penetrate the underlying extracellular matrix (a process referred to as 
delamination) and become highly migratory and invasive (Lim & Thiery 2012). Therefore, 
enhancements in cell proliferation, permeability, migration, and invasion are all functional 
outputs of cells undergoing EndoMT. GATA4 and Twist1 are downstream targets (through 
direct transcriptional activation or through post-translational modifications) of EndoMT 
promoting pathways, i.e. TGFȕ, BMP, Notch and Wnt signalling (Lamouille et al. 2014; 
Daoud et al. 2014; Lin & Xu 2008; Reinhold et al. 2006; George et al. 2015). Interestingly, 
Twist1 and GATA4 can also act as positive regulators of these EndoMT promoting 
SDWKZD\V&KHQHWDO2¶Rourke et al. 2002; Moskowitz et al. 2011). In vivo studies 
have shown that endothelial-specific deletion of Twist1 or GATA4 blocks the EndoMT 
programme and subsequently heart valve formation (Rivera-Feliciano et al. 2006). 
Specifically, the EndoMT-promoting mechanism of Twist1 and GATA4 involves the 
WUDQVFULSWLRQDODFWLYDWLRQRIPHVHQFK\PDOJHQHV6QDLO6OXJĮ-Sma, and Cdh2 (Rivera-
Feliciano et al. 2006; Lamouille et al. 2014; Hong et al. 2011; Chakraborty et al. 2010). 
 
Do GATA4 and Twist1 play a role in the adult vasculature and in disturbed flow-
induced atherosclerosis? 
In the disease context, GATA4 and Twist1 have been shown to drive cancer progression 
and survival by mediating metastasis and proliferation (Yang et al. 2004, Wang et al. 
2003, Chia et al. 2015, Takagi et al. 2014). However, the role of GATA4 and Twist1 in the 
adult vasculature and in atherosclerosis is completely unknown. We recently 
demonstrated for the first time that disturbed flow promotes GATA4-dependent induction 
of Twist1 in EC. Studies using the zebrafish embryo revealed that Twist was expressed 
in early embryonic vasculature where it promoted angiogenic sprouting by inducing EC 
proliferation and migration. In adult mammalian arteries, GATA4 and Twist1 were 
expressed preferentially at atheroprone sites exposed to disturbed flow where GATA4-
Twist1 signalling promoted the development of atherosclerosis by inducing EC 
dysfunction (Proliferation, permeability and inflammation) (Mahmoud et al., 2016). 
 
GATA4 and Twist1 expression is enhanced by atheroprone, disturbed flow. 
To investigate the expression of flow-mediated genes, we conducted a microarray study 
on ECs isolated from either disturbed blood flow sites (inner curvature) or non-disturbed 
flow (outer curvature) of the porcine aorta (Serbanovic-Canic et al., 2017). The study 
revealed that hundreds of genes showed differential expression under flow, this gene set 
included Twist1 and GATA4, which were identified as being enriched at the atheroprone, 
disturbed flow site. This observation was validated by qPCR studies of an independent 
cohort of pigs (Figure 1 A-C). Similarly, en face staining of the murine aortic endothelium 
demonstrated elevated levels of Twist1 and GATA4 protein levels at the inner curvature 
of the aortic arch (disturbed flow) compared to the outer curvature (non-disturbed flow) 
(Figure 1 D-F). These observations revealed that the expression of GATA4 and Twist1 is 
driven by atheroprone, disturbed flow in the vasculature. 
 To directly study the effects of disturbed flow on Twist1 and GATA4 expression we used 
in vitro models of flow. Using two complementary systems, an orbital plate or a parallel 
plate system (Warboys et al., 2014, Dardik et al., 2005) ECs were exposed to either low, 
oscillating shear stress (mimicking disturbed flow in vivo) or high, unidirectional shear 
stress (mimicking non-disturbed flow in vivo) and it was observed using both systems that 
low shear stress induced the expression of Twist1 and GATA4 mRNA and protein. To 
conclude, these data showed that disturbed flow drives the expression of GATA4 and 
Twist1 in vitro and in vivo (Mahmoud et al., 2016). 
 
GATA4 and Twist1 function as part of the same pathway during valve formation in 
embryonic development (Lim et al., 2012), thus we hypothesized that GATA4 and Twist1 
may be acting in a pathway in response to disturbed flow in vascular ECs.  We tested this 
hypothesis in vitro using a combination of gene silencing and chromatin 
immunoprecipitation experiments, which revealed that GATA4 acted upstream of Twist1 
in ECs exposed to disturbed flow, where it promoted Twist1 expression through a 
transcriptional mechanism.  To validate these observations in vivo, we assessed the 
effects of EC-specific genetic deletion of GATA4 (GatacKO) on endothelial expression of 
Twist1 in the murine aorta. En face staining demonstrated that the expression of Twist1 
at the disturbed flow area was reduced in GatacKO compared to control Gata4flox/flox mice, 
revealing that GATA4 positively regulates Twist1 in atheroprone, disturbed flow sites in 
vivo (Mahmoud et al., 2016). 
 
GATA4-Twist1 signalling promotes atherosclerosis by driving EC dysfunction. 
Disturbed flow promotes EC dysfunction and subsequently atherosclerosis, since 
GATA4-Twist1 signalling was elevated in ECs at atheroprone, disturbed flow sites, we 
assessed whether GATA4-Twist1 signalling promoted disturbed flow-induced EC 
dysfunction (inflammation, proliferation, and permeability) and atherogenesis. This was 
tested using a combination of complementary approaches consisting of in vitro studies 
using cultured ECs and exposing them to flow using well-controlled systems (orbital plate 
and parallel plate systems) following gene silencing of Twist1 and GATA4 using siRNA, 
and in vivo studies using mice with an endothelial-specific deletion for GATA4 and Twist1. 
The results from these studies revealed that GATA4 and Twist1 promoted EC 
proliferation, permeability and inflammation under disturbed flow, reflecting that GATA4-
Twist1 signalling promotes disturbed flow-induced EC dysfunction. The mechanisms by 
which GATA4-Twist1 signalling could be mediating EC proliferation involved the 
regulation of cell cycle genes such as Cyclins D1, G2, and CDK4 (Mahmoud et al., 2016). 
This observation is consistent with other studies, that have demonstrated the role of 
GATA4 and Twist1 in driving proliferation and cell cycle regulation in other contexts 
(Gitelmann et al., 1997, Chakraborty et al., 2010). Another mechanism by which GATA4-
Twist1 signalling drives EC dysfunction was through the induction of EndoMT (Mahmoud 
et al 2016, Mahmoud et al 2017). 
 
We next investigated whether GATA4-Twist1 signalling promoted atherosclerosis since it 
promoted EC dysfunction under disturbed flow. Using a PCSK9-adenoassociated virus 
(AAV) followed by high fat diet feeding (6 weeks), we induced hypercholesterolemia in 
Gata4cKO and Twist1cKO mice (Figure 2 A). Interestingly, atherosclerotic lesion formation 
was suppressed in mice lacking the GATA4 and Twist1 gene, compared to control mice, 
revealing that GATA4-Twist1 signalling mediated atherogenesis (Figure 2 B). To 
conclude, GATA4-Twist1 signalling drives EC proliferation, permeability, inflammation 
(EC dysfunction) and atherogenesis in response to disturbed flow (Mahmoud et al., 2016). 
 
EndoMT and atherosclerosis. 
Recent studies established the contribution of EndoMT to atherosclerosis (Moonen et al., 
2015, Chen et al., 2015, Evrard et al., 2016). EndoMT has notably been linked to plaque 
progression since the extent of EndoMT observed in human plaques correlates strongly 
with the severity of the disease (Chen et al., 2015, Evrard et al., 2016). Furthermore, 
endothelial lineage tracing studies in the mouse established the occurrence of EndoMT 
during plaque development (Chen et al., 2015; Evrard et al., 2016). These elegant studies 
revealed that a large proportion of aortic EC delaminate and migrate into the 
atherosclerotic lesions and may promote plaque growth by increasing inflammation. 
EndoMT process has also been linked to disease initiation as Chen et al. demonstrated 
that inhibition of FGF, an antagonist of EndoMT, increases lesion initiation in a mouse 
model of atherosclerosis. 
 
As Twist1 and GATA4 are regulators of EndoMT during embryonic development, we 
investigated whether the mechanism for GATA4-Twist1 driven EC dysfunction leading to 
atherosclerosis involves EndoMT. A series of studies revealed that disturbed flow induced 
EndoMT in cultured EC and that GATA4 and Twist1 are positive regulators of this 
process. Further studies revealed that GATA4-Twist1 signalling directly activated the 
transcription factor Snail, a key driver of EndoMT, through a transcriptional mechanism 
(Mahmoud et al., 2017). In addition, we found that GATA4-Twist1-mediated activation of 
Snail contributed to proliferation and permeability under disturbed flow. Collectively, our 
observations reveal that GATA4-Twist1 signalling promotes EC dysfunction under 
disturbed flow via induction of EndoMT (Mahmoud et al., 2016, Mahmoud et al., 2017). 
Our study gives a new insight into the mechanisms controlling EC dysfunction in response 
to disturbed flow aQGLQDFFRUGDQFHZLWK&KHQ¶VVWXGLHVVXJJHVWVWKDW(QGR07SOD\VD
crucial role in the initiation of atherosclerosis. 
 
 Summary 
The role of GATA4 and Twist1 in embryonic development is well established, 
whereas  the role of GATA4 and Twist1 in adult arteries was previously unknown. Here 
we reveal that the developmental GATA4-Twist1 signalling is regulated by mechanical 
forces in adult ECs, where atheroprone disturbed flow induced GATA4 expression in ECs, 
which in turn transcriptionally activated Twist1 expression. GATA4 and Twist1 have been 
shown to be regulated by mechanical forces in other contexts, GATA4 has been shown 
to be activated in cardiac cells in response to mechanical loading of the heart ventricles 
(Tenhunen et al. 2004) and Twist1 to be regulated by mechanical forces exerted by tissue 
deformations during Drosophila embryonic development (Desprat et al., 2008), and in 
response to matrix stiffness in tumour cells (Wei et al., 2015). We show that disturbed 
flow-driven GATA4-Twist1 signalling, promoted EC proliferation, permeability, and 
inflammation, key characteristics of dysfunctional ECs. As a result of inducing EC 
dysfunction, GATA4-Twist1 signalling promoted the development of atherosclerosis 
(Figure 3). We propose that the mechanism by which GATA4-Twist1 signalling promoted 
EC dysfunction and atherosclerosis is in part, mediated by the initiation of EndoMT, a 
process that has been recently linked with the progression of atherosclerosis (Moonen et 
al., 2015, Chen et al., 2015, Evrard et al., 2016). These observations have implications 
for the development of new therapies to prevent the initiation or progression of 
atherosclerosis by targeting EndoMT. 
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